%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Katherine E. Gadek, Hong Wang, Monica N. Hall, Mitchell Sungello, Andrew Libby, Drew MacLaskey, Robert H. Eckel, Bradley B. Olwin
Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 12 0 R/Contents 13 0 R/TrimBox[0 0 612 792]>>
endobj
12 0 obj
[14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R]
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.ref001)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.ref013)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.ref014)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.ref015)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.ref016)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.ref017)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.ref020)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.ref021)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.ref023)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.ref018)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.ref016)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.ref024)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.ref025)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.g001)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.g001)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0190963.g001)>>
endobj
30 0 obj
<>/Border[0 0 0]/A 31 0 R>>
endobj
31 0 obj
<>
endobj
13 0 obj
[32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R]
endobj
32 0 obj
<>stream
q
0.83 0.64 0.02 0 k
543.5717 667.3323 m
548.3339 667.3323 l
h
f*
550.6016 667.3323 m
560.126 667.3323 l
h
f*
455.9811 628.3276 m
465.5055 628.3276 l
h
f*
467.7165 628.3276 m
477.2409 628.3276 l
h
f*
203.4142 563.3008 m
212.9386 563.3008 l
h
f*
462.0472 537.3354 m
471.5717 537.3354 l
h
f*
476.7307 537.3354 m
486.2551 537.3354 l
h
f*
259.3701 511.3134 m
268.8945 511.3134 l
h
f*
274.0535 511.3134 m
283.578 511.3134 l
h
f*
226.4882 446.3433 m
235.9559 446.3433 l
h
f*
438.1228 381.3165 m
447.6472 381.3165 l
h
f*
449.915 381.3165 m
459.4394 381.3165 l
h
f*
287.1496 355.3512 m
296.674 355.3512 l
h
f*
203.4142 139.3512 m
229.7764 139.3512 l
h
f*
344.2394 113.3291 m
369.5811 113.3291 l
h
f*
244.063 87.3071 m
270.2551 87.3071 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(variable)Tj
3.3561 0 Td
(hypertriglyceridemia)Tj
8.5776 0 Td
(in)Tj
1.0318 0 Td
(affected)Tj
3.3279 0 Td
(patients.)Tj
3.5943 0 Td
(In)Tj
1.1055 0 Td
(patients)Tj
3.3732 0 Td
(homozygous)Tj
5.3064 0 Td
(for)Tj
1.389 0 Td
(LPL)Tj
1.8538 0 Td
(deficiency)Tj
-32.9156 -1.3039 Td
(or)Tj
1.0941 0 Td
(compound)Tj
4.6035 0 Td
(heterozygous)Tj
5.4991 0 Td
(mutations)Tj
4.2803 0 Td
(affecting)Tj
3.6567 0 Td
(the)Tj
1.4683 0 Td
(active)Tj
2.5228 0 Td
(enzyme,)Tj
3.5263 0 Td
(high)Tj
2.0069 0 Td
(triglyceride)Tj
4.7622 0 Td
(levels)Tj
2.3754 0 Td
(are)Tj
-35.7956 -1.2982 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9955 0 Td
(markedly)Tj
3.9912 0 Td
(decreased)Tj
4.1386 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(HDL)Tj
2.262 0 Td
(cholesterol,)Tj
4.7792 0 Td
(eruptive)Tj
3.5036 0 Td
(xanthomas,)Tj
4.8415 0 Td
(lipemia)Tj
-33.1594 -1.2983 Td
(retinalis,)Tj
3.6623 0 Td
(enlarged)Tj
3.6567 0 Td
(spleen)Tj
2.7439 0 Td
(and/or)Tj
2.9367 0 Td
(enlarged)Tj
3.6623 0 Td
(liver,)Tj
2.2053 0 Td
(and)Tj
1.7292 0 Td
(acute)Tj
2.33 0 Td
(and/or)Tj
2.9367 0 Td
(chronic)Tj
3.2882 0 Td
(pancreatitis)Tj
4.8642 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
-34.0155 -1.2983 Td
(The)Tj
1.7801 0 Td
(absence)Tj
3.3392 0 Td
(of)Tj
1.0148 0 Td
(bioactive)Tj
3.8041 0 Td
(LPL)Tj
1.8538 0 Td
(in)Tj
1.0375 0 Td
(human)Tj
3.0784 0 Td
(patients)Tj
3.3675 0 Td
(is)Tj
0.8504 0 Td
(treated)Tj
2.9934 0 Td
(with)Tj
2.0012 0 Td
(a)Tj
0.652 0 Td
(severely)Tj
3.3789 0 Td
(fat)Tj
1.2415 0 Td
(restricted)Tj
3.9855 0 Td
(diet)Tj
1.7348 0 Td
(or,)Tj
-36.1131 -1.3039 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6576 0 Td
(small)Tj
2.3244 0 Td
(number)Tj
3.4185 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
3.3676 0 Td
(by)Tj
1.1849 0 Td
(LPL)Tj
1.8538 0 Td
(gene)Tj
2.0806 0 Td
(therapy)Tj
3.2485 0 Td
(using)Tj
2.3868 0 Td
(alipogene)Tj
4.0535 0 Td
(tiparvovec)Tj
4.371 0 Td
(\(S447X)Tj
3.1181 0 Td
(variant\).)Tj
-34.1119 -1.2982 Td
(Despite)Tj
3.2484 0 Td
(tiparvovec)Tj
4.371 0 Td
(reducing)Tj
3.7701 0 Td
(the)Tj
1.474 0 Td
(frequency)Tj
4.1839 0 Td
(of)Tj
1.0148 0 Td
(acute)Tj
2.3301 0 Td
(pancreatitis)Tj
4.8642 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(],)Tj
3.2541 0 Td
(it)Tj
0.7824 0 Td
(was)Tj
1.7008 0 Td
(recently)Tj
-30.9938 -1.2983 Td
(announced)Tj
4.7054 0 Td
(that)Tj
1.7688 0 Td
(the)Tj
1.4684 0 Td
(product)Tj
3.3902 0 Td
(will)Tj
1.6554 0 Td
(not)Tj
1.5704 0 Td
(be)Tj
1.1452 0 Td
(renewed)Tj
3.617 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.4626 0 Td
(treatment)Tj
4.1329 0 Td
(of)Tj
1.0092 0 Td
(LPL)Tj
1.8481 0 Td
(deficiency)Tj
4.2633 0 Td
(in)Tj
1.0318 0 Td
(Europe.)Tj
-34.452 -1.3039 Td
(Importantly,)Tj
5.278 0 Td
(despite)Tj
3.0387 0 Td
(reducing)Tj
3.7758 0 Td
(acute)Tj
2.33 0 Td
(pancreatitis,)Tj
5.0854 0 Td
(fasting)Tj
2.8856 0 Td
(hypertriglyceridemia)Tj
8.5719 0 Td
(improved)Tj
4.1102 0 Td
(only)Tj
-35.0756 -1.2983 Td
(transiently)Tj
4.473 0 Td
(and)Tj
1.7291 0 Td
(dietary)Tj
2.9934 0 Td
(fat)Tj
1.2415 0 Td
(restriction)Tj
4.3597 0 Td
(remained)Tj
4.0308 0 Td
(necessary.)Tj
4.2463 0 Td
(Therefore,)Tj
4.3937 0 Td
(there)Tj
2.2677 0 Td
(continues)Tj
4.1215 0 Td
(to)Tj
1.0262 0 Td
(be)Tj
1.1508 0 Td
(an)Tj
-36.0337 -1.2983 Td
(unmet)Tj
2.8289 0 Td
(need)Tj
2.1373 0 Td
(for)Tj
1.3776 0 Td
(new)Tj
1.8652 0 Td
(therapeutic)Tj
4.7225 0 Td
(approaches)Tj
4.7282 0 Td
(to)Tj
1.0204 0 Td
(treat)Tj
2.0353 0 Td
(both)Tj
2.0523 0 Td
(absolute)Tj
3.5149 0 Td
(and)Tj
1.7235 0 Td
(acquired)Tj
3.6963 0 Td
(LPL)Tj
1.8425 0 Td
(deficiency)Tj
-33.5449 -1.3039 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
1.1962 -1.2982 Td
(A)Tj
0.907 0 Td
(mouse)Tj
2.8573 0 Td
(LPL)Tj
1.8539 0 Td
(knockout)Tj
4.0252 0 Td
(is)Tj
0.8504 0 Td
(neonatal)Tj
3.6623 0 Td
(lethal,)Tj
2.6192 0 Td
(likely)Tj
2.3527 0 Td
(arising)Tj
2.9367 0 Td
(from)Tj
2.2053 0 Td
(a)Tj
0.652 0 Td
(buildup)Tj
3.3449 0 Td
(of)Tj
1.0148 0 Td
(triglycerides)Tj
5.1193 0 Td
(in)Tj
-35.5972 -1.2983 Td
(the)Tj
1.4683 0 Td
(bloodstream)Tj
5.2214 0 Td
(leading)Tj
3.1351 0 Td
(to)Tj
1.0261 0 Td
(insufficient)Tj
4.7282 0 Td
(gas)Tj
1.4796 0 Td
(exchange)Tj
3.9288 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(lungs)Tj
2.3698 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(].)Tj
3.5433 0 Td
(Transgenic)Tj
4.6771 0 Td
(expres-)Tj
-34.0835 -1.3039 Td
(sion)Tj
1.9048 0 Td
(of)Tj
1.0148 0 Td
(LPL)Tj
1.8539 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(liver)Tj
1.9785 0 Td
(or)Tj
1.0999 0 Td
(skeletal)Tj
3.1521 0 Td
(and)Tj
1.7291 0 Td
(cardiac)Tj
3.1011 0 Td
(muscle)Tj
3.0217 0 Td
(of)Tj
1.0148 0 Td
(LPL)Tj
1.8538 0 Td
(knockout)Tj
4.0252 0 Td
(mice)Tj
2.1543 0 Td
(rescues)Tj
3.1125 0 Td
(the)Tj
1.4683 0 Td
(neo-)Tj
-34.9906 -1.2983 Td
(natal)Tj
2.1769 0 Td
(lethality)Tj
3.4186 0 Td
([)Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(23)Tj
0 g
(],)Tj
3.5433 0 Td
(but)Tj
1.5534 0 Td
(does)Tj
2.0409 0 Td
(not)Tj
1.5761 0 Td
(provide)Tj
3.2881 0 Td
(a)Tj
0.652 0 Td
(feasible)Tj
3.1691 0 Td
(model)Tj
2.7439 0 Td
(for)Tj
1.389 0 Td
(treating)Tj
3.3278 0 Td
(human)Tj
3.0728 0 Td
(LPL)Tj
-31.9519 -1.2982 Td
(deficiency.)Tj
4.4843 0 Td
(Infection)Tj
3.8608 0 Td
(of)Tj
1.0091 0 Td
(skeletal)Tj
3.1465 0 Td
(muscle)Tj
3.016 0 Td
(with)Tj
1.9899 0 Td
(an)Tj
1.1962 0 Td
(adeno-associated)Tj
7.0412 0 Td
(virus)Tj
2.1997 0 Td
(encoding)Tj
3.9231 0 Td
(a)Tj
0.652 0 Td
(gain)Tj
1.9275 0 Td
(of)Tj
1.0092 0 Td
(func-)Tj
-35.4555 -1.2983 Td
(tion)Tj
1.8425 0 Td
(human)Tj
3.0727 0 Td
(LPL)Tj
1.8595 0 Td
(\(hLPL\))Tj
3.0614 0 Td
(variant)Tj
3.0274 0 Td
(also)Tj
1.7688 0 Td
(rescues)Tj
3.1124 0 Td
(the)Tj
1.4684 0 Td
(neonatal)Tj
3.6623 0 Td
(lethality)Tj
3.4129 0 Td
(but)Tj
1.5534 0 Td
(is)Tj
0.8504 0 Td
(transient,)Tj
3.9968 0 Td
(as)Tj
1.0148 0 Td
(these)Tj
-33.7037 -1.3039 Td
(viruses)Tj
2.9876 0 Td
(do)Tj
1.253 0 Td
(not)Tj
1.5703 0 Td
(integrate)Tj
3.7531 0 Td
(into)Tj
1.8425 0 Td
(the)Tj
1.4683 0 Td
(genome)Tj
3.4073 0 Td
(and)Tj
1.7291 0 Td
(hLPL)Tj
2.3811 0 Td
(expression)Tj
4.4673 0 Td
(decreases)Tj
3.9685 0 Td
(over)Tj
1.9786 0 Td
(time.)Tj
2.2507 0 Td
(However,)Tj
-33.0574 -1.2983 Td
(these)Tj
2.2506 0 Td
(data)Tj
1.9163 0 Td
(suggest)Tj
3.1237 0 Td
(that)Tj
1.7745 0 Td
(a)Tj
0.6576 0 Td
(permanent)Tj
4.6035 0 Td
(skeletal)Tj
3.1464 0 Td
(muscle)Tj
3.0217 0 Td
(targeted)Tj
3.4639 0 Td
(gene)Tj
2.0806 0 Td
(therapy)Tj
3.2485 0 Td
(could)Tj
2.4491 0 Td
(prove)Tj
2.4945 0 Td
(effica-)Tj
-34.2309 -1.2983 Td
(cious)Tj
2.3073 0 Td
([)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
2.075 0 Td
(To)Tj
1.3379 0 Td
(test)Tj
1.5988 0 Td
(whether)Tj
3.4809 0 Td
(a)Tj
0.6519 0 Td
(skeletal)Tj
3.1465 0 Td
(muscle)Tj
3.0217 0 Td
(targeted)Tj
3.4639 0 Td
(gene)Tj
2.0806 0 Td
(therapy)Tj
3.2485 0 Td
(can)Tj
1.6271 0 Td
(rescue)Tj
2.7496 0 Td
(LPL)Tj
1.8538 0 Td
(deficiency,)Tj
4.4901 0 Td
(a)Tj
-37.1336 -1.3039 Td
(mouse)Tj
2.8573 0 Td
(model)Tj
2.7439 0 Td
(that)Tj
1.7801 0 Td
(more)Tj
2.3414 0 Td
(closely)Tj
2.88 0 Td
(mimics)Tj
3.1805 0 Td
(the)Tj
1.4683 0 Td
(human)Tj
3.0784 0 Td
(phenotype)Tj
4.439 0 Td
(with)Tj
1.9956 0 Td
(hypertriglyceridemia)Tj
8.5719 0 Td
(and)Tj
-35.3364 -1.2982 Td
(decreased)Tj
4.1328 0 Td
(LPL)Tj
1.8596 0 Td
(blood)Tj
2.5114 0 Td
(activity)Tj
3.1181 0 Td
(is)Tj
0.8504 0 Td
(needed.)Tj
3.3165 0 Td
(Previous)Tj
3.6907 0 Td
(attempts)Tj
3.6737 0 Td
(have)Tj
2.0579 0 Td
(generated)Tj
4.1386 0 Td
(skeletal)Tj
3.1464 0 Td
(or)Tj
1.0999 0 Td
(cardiac)Tj
-33.596 -1.2983 Td
(muscle-specific)Tj
6.3438 0 Td
(knockouts)Tj
4.3824 0 Td
(of)Tj
1.0148 0 Td
(LPL)Tj
1.8595 0 Td
(but)Tj
1.5477 0 Td
(they)Tj
1.9275 0 Td
(do)Tj
1.253 0 Td
(not)Tj
1.576 0 Td
(mimic)Tj
2.8176 0 Td
(the)Tj
1.4684 0 Td
(human)Tj
3.0784 0 Td
(phenotypes.)Tj
5.0229 0 Td
(A)Tj
0.9071 0 Td
(skeletal)Tj
-33.1991 -1.3039 Td
(muscle-specific)Tj
6.3438 0 Td
(knockout)Tj
4.0252 0 Td
(increases)Tj
3.8324 0 Td
(insulin)Tj
2.9821 0 Td
(sensitivity)Tj
4.2236 0 Td
(in)Tj
1.0374 0 Td
(muscle,)Tj
3.2485 0 Td
(causing)Tj
3.2428 0 Td
(obesity)Tj
3.0388 0 Td
(and)Tj
1.7291 0 Td
(systemic)Tj
-33.7037 -1.2983 Td
(insulin)Tj
2.9876 0 Td
(resistance,)Tj
4.354 0 Td
(but)Tj
1.5534 0 Td
(does)Tj
2.0409 0 Td
(not)Tj
1.5704 0 Td
(cause)Tj
2.3925 0 Td
(hypertriglyceridemia)Tj
8.5719 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(24)Tj
0 g
(].)Tj
3.2541 0 Td
(Cardiac)Tj
3.3449 0 Td
(muscle-specific)Tj
-30.0697 -1.2983 Td
(knockouts)Tj
4.3823 0 Td
(of)Tj
1.0148 0 Td
(LPL)Tj
1.8595 0 Td
(induce)Tj
2.9367 0 Td
(hypertriglyceridemia,)Tj
8.7987 0 Td
(but)Tj
1.5533 0 Td
(had)Tj
1.7121 0 Td
(no)Tj
1.2756 0 Td
(effect)Tj
2.3641 0 Td
(on)Tj
1.2756 0 Td
(LPL)Tj
1.8538 0 Td
(activity)Tj
3.1181 0 Td
(measured)Tj
4.1102 0 Td
(in)Tj
-36.2548 -1.2982 Td
(post-heparin)Tj
5.3404 0 Td
(plasma)Tj
3.033 0 Td
([)Tj
0.83 0.64 0.02 0 k
(25)Tj
0 g
(].)Tj
2.075 0 Td
(Therefore,)Tj
4.3937 0 Td
(we)Tj
1.3266 0 Td
(reasoned)Tj
3.821 0 Td
(that)Tj
1.7745 0 Td
(a)Tj
0.6577 0 Td
(skeletal)Tj
3.1464 0 Td
(and)Tj
1.7291 0 Td
(cardiac)Tj
3.1011 0 Td
(muscle-specific)Tj
-30.3985 -1.3039 Td
(knockout)Tj
4.0251 0 Td
(of)Tj
1.0148 0 Td
(LPL)Tj
1.8539 0 Td
(would)Tj
2.7155 0 Td
(provide)Tj
3.2882 0 Td
(a)Tj
0.652 0 Td
(model)Tj
2.7439 0 Td
(that)Tj
1.7801 0 Td
(more)Tj
2.3414 0 Td
(closely)Tj
2.88 0 Td
(mimics)Tj
3.1805 0 Td
(human)Tj
3.0727 0 Td
(LPL)Tj
1.8595 0 Td
(deficiency)Tj
4.2633 0 Td
(and)Tj
-35.6709 -1.2983 Td
(allow)Tj
2.3357 0 Td
(us)Tj
1.1112 0 Td
(to)Tj
1.0204 0 Td
(test)Tj
1.6044 0 Td
(a)Tj
0.652 0 Td
(muscle-specific)Tj
6.3439 0 Td
(gene)Tj
2.0806 0 Td
(therapy.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 280.4031 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Results)Tj
/F0 1 Tf
0 -1.5023 Td
(Mice)Tj
2.3102 0 Td
(lacking)Tj
3.2835 0 Td
(striated)Tj
3.463 0 Td
(muscle)Tj
3.3544 0 Td
(lipoprotein)Tj
4.7622 0 Td
(lipase)Tj
2.7922 0 Td
(develop)Tj
-19.9655 -1.1622 Td
(hypertriglyceridemia)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 231.4204 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(To)Tj
1.3379 0 Td
(develop)Tj
3.3165 0 Td
(a)Tj
0.6576 0 Td
(tractable)Tj
3.6567 0 Td
(model)Tj
2.7439 0 Td
(to)Tj
1.0262 0 Td
(test)Tj
1.5987 0 Td
(rescuing)Tj
3.6056 0 Td
(LPL)Tj
1.8596 0 Td
(deficiencies)Tj
4.8642 0 Td
(in)Tj
1.0318 0 Td
(adult)Tj
2.2563 0 Td
(mice)Tj
2.1544 0 Td
(we)Tj
1.3266 0 Td
(asked)Tj
2.4604 0 Td
(if)Tj
0.7767 0 Td
(knock-)Tj
-34.6731 -1.3039 Td
(ing)Tj
1.5023 0 Td
(out)Tj
1.5477 0 Td
(LPL)Tj
1.8595 0 Td
(in)Tj
1.0318 0 Td
(differentiated)Tj
5.6069 0 Td
(striated)Tj
3.2032 0 Td
(\(skeletal)Tj
3.4922 0 Td
(and)Tj
1.7291 0 Td
(cardiac\))Tj
3.4413 0 Td
(muscle)Tj
3.0217 0 Td
(using)Tj
2.3867 0 Td
(a)Tj
0.6577 0 Td
(muscle)Tj
3.016 0 Td
(creatine)Tj
-32.4961 -1.2982 Td
(kinase)Tj
2.7495 0 Td
(\(mck\))Tj
2.6419 0 Td
(Cre)Tj
1.6781 0 Td
(would)Tj
2.7099 0 Td
(cause)Tj
2.3924 0 Td
(both)Tj
2.058 0 Td
(hypertriglyceridemia)Tj
8.5719 0 Td
(and)Tj
1.7348 0 Td
(lower)Tj
2.4491 0 Td
(post-heparin)Tj
5.3461 0 Td
(plasma)Tj
3.0331 0 Td
(LPL)Tj
-35.3648 -1.2983 Td
(activity.)Tj
3.3391 0 Td
(Mice)Tj
2.2281 0 Td
(homozygous)Tj
5.3121 0 Td
(\()Tj
/F10 1 Tf
[()6()13()13()20( )10(\n)10( )]TJ
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 357.1086 196.8377 cm
BT
/F10 1 Tf
1 TL
-0.0053 Tc
0 0 Td
[()]TJ
ET
Q
q
1 j
1 J
0 w
10 0 0 10 364.3653 192.4157 cm
BT
/F10 1 Tf
1 TL
-0.004 Tc
0 0 Td
[()]TJ
/F5 1 Tf
0.5385 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.4684 0 Td
(floxed)Tj
2.6815 0 Td
(LPL)Tj
1.8539 0 Td
(gene)Tj
2.0806 0 Td
(\(LPL)Tj
2.194 0 Td
(cKO\))Tj
2.4038 0 Td
(or)Tj
1.0998 0 Td
(heterozygous)Tj
-32.1389 -1.3039 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(floxed)Tj
2.6759 0 Td
(LPL)Tj
1.8538 0 Td
(gene)Tj
2.0806 0 Td
(were)Tj
2.1203 0 Td
(bred,)Tj
2.2791 0 Td
(exhibited)Tj
3.923 0 Td
(normal)Tj
3.1464 0 Td
(Mendelian)Tj
4.5354 0 Td
(ratios)Tj
2.4605 0 Td
(at)Tj
0.9524 0 Td
(birth)Tj
2.1884 0 Td
(and)Tj
1.7291 0 Td
(appeared)Tj
-32.8022 -1.2982 Td
(healthy)Tj
3.1294 0 Td
(\(data)Tj
2.2564 0 Td
(not)Tj
1.5704 0 Td
(shown\).)Tj
3.4185 0 Td
(In)Tj
1.1055 0 Td
(six-month-old)Tj
5.998 0 Td
(mice,)Tj
2.3811 0 Td
(LPL)Tj
1.8538 0 Td
(mRNA)Tj
3.0784 0 Td
(was)Tj
1.7008 0 Td
(nearly)Tj
2.6986 0 Td
(undetectable)Tj
5.3007 0 Td
(in)Tj
-34.4916 -1.2983 Td
(either)Tj
2.5285 0 Td
(skeletal)Tj
3.1521 0 Td
(muscle)Tj
3.0217 0 Td
(tissue)Tj
2.4548 0 Td
(or)Tj
1.0998 0 Td
(cardiac)Tj
3.1011 0 Td
(tissue)Tj
2.4603 0 Td
(from)Tj
2.2054 0 Td
(LPL)Tj
1.8538 0 Td
(cKO)Tj
2.0636 0 Td
(mice)Tj
2.1544 0 Td
(compared)Tj
4.2462 0 Td
(to)Tj
1.0262 0 Td
(wild)Tj
1.9445 0 Td
(type)Tj
1.9106 0 Td
(mice)Tj
-35.223 -1.2983 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8198 0 Td
(1A)Tj
0 g
(,)Tj
1.6044 0 Td
(p)Tj
/F11 1 Tf
0 Tc
(<)Tj
/F5 1 Tf
-0.004 Tc
(0.02\).)Tj
3.7247 0 Td
(Consistent)Tj
4.4957 0 Td
(with)Tj
2.0013 0 Td
(the)Tj
1.4683 0 Td
(low)Tj
1.6553 0 Td
(level)Tj
2.0183 0 Td
(of)Tj
1.0148 0 Td
(LPL)Tj
1.8538 0 Td
(mRNA,)Tj
3.3052 0 Td
(tissue)Tj
2.4605 0 Td
(specific)Tj
3.1918 0 Td
(LPL)Tj
1.8538 0 Td
(activity)Tj
3.1181 0 Td
(in)Tj
-35.5858 -1.3039 Td
(LPL)Tj
1.8538 0 Td
(cKO)Tj
2.0636 0 Td
(mice)Tj
2.1544 0 Td
(compared)Tj
4.2462 0 Td
(to)Tj
1.0205 0 Td
(wild)Tj
1.9502 0 Td
(type)Tj
1.9106 0 Td
(was)Tj
1.7006 0 Td
(10-fold)Tj
3.0898 0 Td
(lower)Tj
2.4548 0 Td
(in)Tj
1.0318 0 Td
(skeletal)Tj
3.1521 0 Td
(muscle)Tj
3.0217 0 Td
(and)Tj
1.7291 0 Td
(50-fold)Tj
3.0898 0 Td
(lower)Tj
-34.469 -1.2982 Td
(in)Tj
1.0318 0 Td
(cardiac)Tj
3.1011 0 Td
(muscle)Tj
3.0217 0 Td
(than)Tj
2.0296 0 Td
(in)Tj
1.0374 0 Td
(wild)Tj
1.9446 0 Td
(type)Tj
1.9162 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8198 0 Td
(1B)Tj
0 g
(,)Tj
1.4966 0 Td
(p)Tj
/F11 1 Tf
0 Tc
(<)Tj
/F5 1 Tf
-0.004 Tc
(0.02\).)Tj
3.7304 0 Td
(The)Tj
1.7801 0 Td
(reduction)Tj
4.1159 0 Td
(in)Tj
1.0375 0 Td
(LPL)Tj
1.8538 0 Td
(expression)Tj
4.4674 0 Td
(and)Tj
-34.3839 -1.2983 Td
(LPL)Tj
1.8538 0 Td
(activity)Tj
3.1181 0 Td
(increased)Tj
4.0025 0 Td
(fasting)Tj
2.88 0 Td
(serum)Tj
2.7212 0 Td
(triglyceride)Tj
4.7621 0 Td
(levels)Tj
2.3754 0 Td
(in)Tj
1.0375 0 Td
(LPL)Tj
1.8538 0 Td
(cKO)Tj
2.0637 0 Td
(mice)Tj
2.1543 0 Td
(compared)Tj
4.2406 0 Td
(to)Tj
1.0261 0 Td
(wild-)Tj
-34.0891 -1.3039 Td
(type)Tj
1.9105 0 Td
(mice)Tj
2.1543 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8199 0 Td
(1C)Tj
0 g
(,)Tj
1.5874 0 Td
(p)Tj
/F11 1 Tf
0 Tc
(<)Tj
/F5 1 Tf
-0.004 Tc
(0.0001\).)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 361.1338 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Muscle)Tj
3.3307 0 Td
(gene)Tj
2.4024 0 Td
(therapy)Tj
3.5008 0 Td
(treatment)Tj
4.3795 0 Td
(for)Tj
1.3678 0 Td
(lipoprotein)Tj
4.7339 0 Td
(lipase)Tj
2.7779 0 Td
(deficiency)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01909)Tj
4.089 0 Td
(63)Tj
0 g
2.0906 0 Td
(January)Tj
3.7205 0 Td
(5,)Tj
1.0417 0 Td
(2018)Tj
34.1436 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
BT
66.402 0 Td
(13)Tj
ET
Q
endstream
endobj
48 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 54 0 R/Contents 55 0 R/TrimBox[0 0 612 792]>>
endobj
53 0 obj
<>stream
xu]Ž>[@C`m&@@;ZkBn
Ez{?\]wm9>{?Y{Yf<_//?>y)ӊ[n{F[z@ @_ KKt݉6@ @'}7zeYfW^eZq0bĈZ;Ϟ@ =Bwi&l3l]5^{&L?~SN9k}g~=E\@ Bq?fm'qq @ >#OE/383}ρC]m<@^n @ =K,QkeY{>M4@ 4g}FYka/}Kw7p'xG@ @ uYd|+'tRD @c~k-L=8կ~k?V @ 7[mZ??N>@1?N'8]{_xX{Q+@ SNc934E]Ks@ F1c*&wZqqG͘D@ @ ΞzꩥU[X?Ll
O矋X(l~/b]تC}Ao+:q2@qo#GzFm?KN++?-[N`@ @# RK-UI-+?w}@nf+$^z.8)|8tAgq8=Ss|G\qo;q j1_^ Ӓ0O_|e/,mSJ.x뭷vroQ @ 0tM$x0}3>~8ꨣ?
l=裒7|~fa9\s5%C6(q̅^خkev{ws].̾=ҬΪ{M7T\߈Q@ &騯u&[믿.|[*hzDU@ @ {2@*-M7+^p-ۂё4XZÇkn9b
ON)\ob莏;84^R-Cg}vnjZX @-9l0
tғ4՜\ZL&^4u@ @`/pww+}Eaww#V=W_B}HFDJT|LS &٬.[Ծn'O|'jz-#<.,fOROAfچf%q&3&W
"o< ]mFQ-@ 2[
ZpKK0m&⋗gP:Ȯ1bUX>y8@`:`r%"[l15j3lg֕VZ ˙u3ltv0*@ b$xD;icvoN=@`qu֡JMŀw?: :[o+|'SY[N8!1;Ro%V_}us}R9rbgqzyGXIN$K[&uqP9ڭ|\ǁ@ t6fֳ,py b1c_|ߟ] @!p-:f9qD3%CDT{:c:u6pQ4@(}]k(4Yx:Szd*2DU?~<~IXڄ
+i5[MP1V7t^X:J@ tK/F
ł5l2PDTOF:@ @!@K6Lf`>:,B]t{"-9kW%'+ZKრF8y)$XdI&%6J,l1K.$ɮmF֝VXc
_1}W*og@ `j1Mb|d4feС%T:Z @ Я H!1וl)vmWF)؋kZq*qƱFrՠ=BH0J do'